跳至主要内容
临床试验/NCT02876484
NCT02876484已完成4 期

Effects of Chenodeoxycholic Acid and Colesevelam on GLP-1 Secretion, During a Meal, After Roux-en-Y Gastric Bypass

Hvidovre University Hospital1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2016年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
12
试验地点
1
主要终点
GLP-1 secretion (evaluated by iAUC)

研究概览

简要总结

The purpose of this study is to examine the effects of bile acid and bile acids sequestrants on GLP-1 Secretion, during a meal, in patients after Roux-en-Y gastric bypass.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Uncomplicated RYGB performed minimum 3 months prior to the study.
  • Fasting plasma glucose < 7,0 mM, HbA1c < 48 mmol/mol 3 months after RYGB

排除标准

  • Fasting plasma glucose > 7,0 mM, HbA1c > 48 mmol/mol 3 months after RYGB.
  • Dysregulated thyroid diseases, use of antithyroid treatment.
  • Late diabetic complications as retinopathy, renal insufficiency, neuropathy or previous pancreatitis.
  • Complications to RYGB. Documented reactive hypoglycaemia, severe dumping (vomiting, diarrhea, severe abdominal pain after food intake).
  • Cholecystectomy

研究组 & 干预措施

Placebo

Experimental

Morning meal: brown bread, margarine, cheese, yoghurt, oatmeal, raisins, almonds, water, PCM.

25 ml water

干预措施: Water (Other)

Chenodeoxycholic Acid

Experimental

Morning meal: brown bread, margarine, cheese, yoghurt, oatmeal, raisins, almonds, water, PCM. Chenodeoxycholic acid (1250 mg) mixed in 25 ml yoghurt

干预措施: Chenodeoxycholic Acid (Drug)

Colesevelam

Experimental

Morning meal: brown bread, margarine, cheese, yoghurt, oatmeal, raisins, almonds, water, PCM. Colesevelam (3,75 g) dissolved in 25 ml water and mixed in 25 ml yoghurt.

干预措施: Colesevelam (Drug)

Colesevelam x 2

Experimental

plus (on another study day) 3,75 g colesevelam administered the evening before the experiment. Morning meal: brown bread, margarine, cheese, yoghurt, oatmeal, raisins, almonds, water, PCM. Colesevelam (3,75 g) dissolved in 25 ml water and mixed in 25 ml yoghurt.

干预措施: Colesevelam (Drug)

结局指标

主要结局

GLP-1 secretion (evaluated by iAUC)

时间窗: -10, 0, 10, 20, 30, 45, 60, 90, 120, 180 and 240 minutes after mixed meal

次要结局

  • Insulin secretion(-10, 0, 10, 20, 30, 45, 60, 90, 120, 180 and 240 minutes)
  • PYY secretion(-10, 0, 10, 20, 30, 45, 60, 90, 120, 180 and 240 minutes)
  • Bile acids/FGF19 concentrations(-10, 0, 10, 20, 30, 45, 60, 90, 120, 180 and 240 minutes)
  • Glucose levels(-10, 0, 10, 20, 30, 45, 60, 90, 120, 180 and 240 minutes)
  • PCM levels(Baseline, 0, 5, 10, 15, 20, 30, 45, 60, 90, 120, 180, 240 minutes)
  • CCK secretion(0, 10, 20, 30, 45, 60, 90, 120, 180 and 240 minutes)
  • Total bile acid secretion(0, 10, 20, 30, 45, 60, 90, 120, 180 and 240 minutes)
  • Appetite measurements (VAS-score)(0, 10, 20, 30, 45, 60, 90, 120, 180 and 240 minutes)
  • C-peptide secretion(Baseline, 0, 5, 10, 20, 30, 45, 60, 90, 120, 180, 240 minutes)
  • Glucagon secretion(Baseline, 0, 10, 20, 30, 45, 60, 90, 120, 180, 240 minutes)
  • GIP secretion(0, 10, 20, 30, 45, 60, 90, 120, 180 and 240 minutes)
  • Ghrelin(0, 10, 20, 30, 45, 60, 90, 120, 180 and 240 minutes)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Maria Saur Svane

MD

Hvidovre University Hospital

研究点 (1)

Loading locations...

相似试验

Effects of Bile Acids and Bile Acid Sequestrants on... | 临床试验